We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Matrix’s Generic Kaletra Wins Tentative FDA Approval
Matrix’s Generic Kaletra Wins Tentative FDA Approval
March 17, 2009
A Mylan subsidiary has received tentative FDA approval to sell a generic version of Abbott Laboratories’ Kaletra HIV treatment.